Avtor/Urednik		Gašljević, Gorana; Matter, Matthias S.; Blatnik, Olga; Unk, Mojca; Dirnhofer, Stefan
Naslov		NUT Carcinoma
Tip		članek
Vol. in št.		Letnik 30, št. 3
Leto izdaje		2022
Obseg		str. 273‐277
ISSN		1066-8969 - International journal of surgical pathology
Jezik		eng
Abstrakt		: NUT carcinoma is a highly aggressive and rare subset of squamous cell carcinoma with grim prognosis. It is under-recognized by both pathologists and oncologists. Recognition is challenging due to its rareness and the fact that its clinical and laboratory features as well as morphological and immunohistochemical characteristics may mimic other malignancies. Case presentation: An interesting case of NUT carcinoma in a 47-year-old male with a large tumor mass in the inferior part of the mediastinum and left lung and increased levels of serum alpha fetoprotein (AFP) is described. Immunohistochemical analysis of both the primary tumor in a bronchoscopy specimen and an excisional biopsy of a subcutaneous metastasis showed positivity for AFP and leukocyte common antigen (LCA) that were misleading and resulted in diagnostic pitfalls of mediastinal germ cell tumor (clinically) and hematolymphoid neoplasm (pathologic report). Immunohistochemical demonstration of NUT protein expression revealed the proper diagnosis, which was further confirmed by RNA sequencing revealing a BRD4-NUTM1 gene fusion.Conclusions: Since NUT carcinoma can show a wide spectrum of histological and immunophenotypic features and can clinically mimic other tumors, use of RNA sequencing with identification of specific NUTM1 fusion partner could be crucial when there are discrepant clinical and histopathological findings. As well, since the category of so-called NUTM1-rearranged neoplasms is rapidly expanding, identification of NUTM1 fusion partner may be essential for the appropriate clinical management.
Proste vsebinske oznake		rak NUT ploščatocelični rak imunohistokemija sekvencioniranje RNK NUT carcinoma squamous cell carcinoma immunohistochemistry RNA sequencing